<DOC>
	<DOCNO>NCT03053180</DOCNO>
	<brief_summary>This prospective , multi-center , observational study design assess real world effectiveness safety paritaprevir/r - ombitasvir dasabuvir ( 3DAA [ direct-acting antiviral agent ] ABBVIE REGIMEN ) without ribavirin ( RBV ) participants chronic hepatitis C virus ( HCV ) genotype 1b ( GT1b ) infection compensate liver cirrhosis Russia .</brief_summary>
	<brief_title>Real World Evidence Effectiveness Paritaprevir/r - Ombitasvir , + Dasabuvir Without Ribavirin Participants With Chronic Hepatitis C Compensated Liver Cirrhosis Russian Federation</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>ABBVIE REGIMEN prescribe physician accord routine clinical practice Treatmentna√Øve IFN/RBVexperienced participant confirm CHC Gt1b compensate liver cirrhosis , receive therapy interferonfree ABBVIE 3D REGIMEN initiate earlier 2 week enrollment initiation plan later 2 week day enrollment accordance standard care line current local label Participants must participate intend participate concurrent interventional therapeutic trial Coadministration ribavirin ( RBV ) ABBVIE REGIMEN Participants Child Pugh B C cirrhosis Participants history prior directacting antiviral agent ( DAA ) therapy Any contraindication administration ABBVIE REGIMEN accord label</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Ombitasvir</keyword>
	<keyword>Dasabuvir</keyword>
	<keyword>Hepatitis</keyword>
	<keyword>Chronic Hepatitis C genotype 1b ( GT1b )</keyword>
	<keyword>Paritaprevir</keyword>
	<keyword>Cirrhosis</keyword>
	<keyword>Compensated liver cirrhosis</keyword>
	<keyword>Ribavirin free</keyword>
	<keyword>Ritonavir</keyword>
</DOC>